GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
TIL Therapy in cSCC and MCC
- Status
- RECRUITING
- Phase
- PHASE2
Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
BrEto-TCL - Defining the Role of Brentuximab and Etoposide for Optimizing First-line Therapy of T-cell Lymphomas
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
- Status
- RECRUITING
- Phase
- PHASE2
ALL Backbone in AYAs
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE3
Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas
- Status
- RECRUITING
- Phase
- PHASE1
Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy: A Phase I Pilot Safety and Feasibility Study for Solid Tumor Patients With CNS Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- Status
- RECRUITING
- Phase
- PHASE1
A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC
- Status
- RECRUITING
- Phase
- PHASE1
Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma
- Status
- RECRUITING
- Phase
- PHASE3
BDB-001 Phase III Trial in ANCA-Associated Vasculitis
- Status
- RECRUITING
- Phase
- PHASE3
Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1